1518742355364524034

Today we presented details on our lead advanced cell therapy candidate, omidubicel, in a study awarded TCT’s Best Abstract! Learn more here: https://t.co/tIPbNA8SZa
#Tandem22 https://t.co/NZc9XmdXLL

Send us a message